| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9341019 | Urologic Oncology: Seminars and Original Investigations | 2005 | 5 Pages |
Abstract
The role of proinflammatory cytokines in biochemical pathways of neoplastic growth has been established in prostate cancer, along with evidence for high levels of interleukin (IL)-6 among patients with hormone refractory disease. However, little is known about the frequency of a SIS in patients with prostatic carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Davide M.D., George M.D., Christos M.D., Marzanna M.D., Nicholas (Prof.),